Comparative Study between the CRISPR/Cpf1 (Cas12a) and CRISPR/Cas9 Systems for Multiplex Gene Editing in Maize

被引:13
|
作者
Gong, Chongzhi [1 ]
Huang, Shengchan [1 ]
Song, Rentao [2 ]
Qi, Weiwei [1 ]
机构
[1] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200444, Peoples R China
[2] China Agr Univ, Coll Agron & Biotechnol, Natl Maize Improvement Ctr,Joint Int Res Lab Crop, State Key Lab Plant Physiol & Biochem,Beijing Key, Beijing 100193, Peoples R China
来源
AGRICULTURE-BASEL | 2021年 / 11卷 / 05期
基金
中国国家自然科学基金;
关键词
multiplex gene editing; Cpf1; CRISPR/Cas; maize genetics; editing efficiency; GENOME; CRISPR-CAS9; CPF1; ENDONUCLEASE; NUCLEASES; CLEAVAGE; BACTERIA; COMPLEX; RICE; RNAS;
D O I
10.3390/agriculture11050429
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Although the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has been proved to be an efficient multiplex gene editing system in maize, it was still unclear how CRISPR/Cpf1 (Cas12a) system would perform for multiplex gene editing in maize. To this end, this study compared the CRISPR/Cpf1 system and CRISPR/Cas9 system for multiplex gene editing in maize. The bZIP transcription factor Opaque2 (O2) was used as the target gene in both systems. We found that in the T0 and T1 generations, the CRISPR/Cpf1 system showed lower editing efficiency than the CRISPR/Cas9 system. However, in the T2 generation, the CRISPR/Cpf1 system generated more types of new mutations. While the CRISPR/Cas9 system tended to edit within the on-target range, the CRISPR/Cpf1 system preferred to edit in between the targets. We also found that in the CRISPR/Cpf1 system, the editing efficiency positively correlated with the expression level of Cpf1. In conclusion, the CRISPR/Cpf1 system offers alternative choices for target-site selection for multiplex gene editing and has acceptable editing efficiency in maize and is a valuable alternative choice for gene editing in crops.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The Cpf1 CRISPR-Cas protein expands genome-editing tools
    Robert D. Fagerlund
    Raymond H. J. Staals
    Peter C. Fineran
    Genome Biology, 16
  • [42] Efficient multiplex genome editing by CRISPR/Cas9 in common wheat
    Li, Jihu
    Zhang, Shujuan
    Zhang, Rongzhi
    Gao, Jie
    Qi, Yiping
    Song, Guoqi
    Li, Wei
    Li, Yulian
    Li, Genying
    PLANT BIOTECHNOLOGY JOURNAL, 2021, 19 (03) : 427 - 429
  • [43] Development of a CRISPR/Cpf1 system for multiplex gene editing in Aspergillus oryzae
    Tianming Chen
    Ziming Chen
    Huanxin Zhang
    Yuzhen Li
    Lihua Yao
    Bin Zeng
    Zhe Zhang
    Folia Microbiologica, 2024, 69 : 373 - 382
  • [44] Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
    Bernd Zetsche
    Matthias Heidenreich
    Prarthana Mohanraju
    Iana Fedorova
    Jeroen Kneppers
    Ellen M DeGennaro
    Nerges Winblad
    Sourav R Choudhury
    Omar O Abudayyeh
    Jonathan S Gootenberg
    Wen Y Wu
    David A Scott
    Konstantin Severinov
    John van der Oost
    Feng Zhang
    Nature Biotechnology, 2017, 35 : 31 - 34
  • [45] CRISPR-Directed In Vitro Gene Editing of Plasmid DNA Catalyzed by Cpf1 (Cas12a) Nuclease and a Mammalian Cell-Free Extract
    Sansbury, Brett M.
    Wagner, Amanda M.
    Nitzan, Erez
    Tarcic, Gabi
    Kmiec, Eric B.
    CRISPR JOURNAL, 2018, 1 (02): : 191 - 202
  • [46] CRISPR/CAS9 GENE EDITING TO BLOCK MALARIA TRANSMISSION
    Simoes, Maria
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 262 - 262
  • [47] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
    Naso, Gaetano
    Petrova, Anastasia
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
  • [48] CRISPR/Cas9 gene editing therapies for cystic fibrosis
    Graham, Carina
    Hart, Stephen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 767 - 780
  • [49] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [50] CRISPR/CAS9 GENE EDITING APPLICATIONS IN CARDIOVASCULAR DISEASE
    Khouzam, J.
    Khouzam, R.
    Tivakaran, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 423 - 424